What does the IHI stand for?

Written by Editorial Team | Last Updated: August 2026

IHI Corporation, historically known as Ishikawajima-Harima Heavy Industries, is a major Japanese multinational engineering enterprise that designs, manufactures, and constructs heavy industrial machinery, aerospace equipment, and infrastructure systems. The corporation's massive product portfolio encompasses commercial aircraft jet engines, rocket propulsion components, marine ship engines, massive bridge structures, turbomachinery, thermal power plants, and industrial boilers. By delivering high-precision heavy engineering solutions, IHI plays a crucial role in supporting global transportation, aerospace exploration, energy generation, and civil infrastructure development.

Related FAQs

The iShares U.S. Healthcare Providers ETF (IHF) invests heavily in major corporations dominating the American managed healthcare, insurance, and medical services sectors.

Ishikawajima-Harima Heavy Industries (IHI Corporation) is a leading Japanese engineering and manufacturing company that plays a crucial role in heavy industry.

IHI Corporation trades on the Tokyo Stock Exchange under the stock code 7013, reflecting its prominent status as a heavy industrial engineering heavyweight in Japan.

Seven & i Holdings stock—representing ownership in the parent corporation of 7-Eleven—provides regular dividend payments to eligible investors.

The Health Care Select Sector SPDR Fund (XLV) and the Vanguard Health Care ETF (VHT) are widely regarded as the best healthcare exchange-traded funds for investors seeking diversified exposure to the sector.

IHI Corporation generates massive annual consolidated net revenues exceeding ¥1.62 trillion to over ¥1.

The iShares U.S. Medical Devices ETF (IHI) tracks an index composed of domestic manufacturers and distributors of medical equipment, medical devices, and healthcare supplies.

In global industrial engineering and corporate market listings, IHI stands for Ishikawajima-Harima Heavy Industries, now operating officially as IHI Corporation.

Specialized exchange-traded funds or medical device manufacturing corporations designated under the IHI ticker look toward a strong future outlook driven by advancing healthcare technologies, surgical robotics, and cardiovascular innovations.

The iShares U.S. Medical Devices ETF (NYSE Arca: IHI) trades at $54.21 per share, reflecting a massive fund asset base exceeding $3.25 billion. Tracking the performance of U.S.

Yes, thanks to the availability of fractional shares through various online financial services and brokerage apps, you can start investing with as little as $1.

Investors can purchase shares in select subsidiaries of the Abu Dhabi National Oil Company, as the state-owned energy giant has executed initial public offerings for several key business units—such as ADNOC Distribution, ADNOC Drilling, and ADNOC Gas...

The Triple Aim framework, developed by the Institute for Healthcare Improvement (IHI), outlines three critical optimization dimensions for healthcare systems: improving the individual experience of care (including quality and satisfaction), improving...

Multiple exchange-traded funds focus specifically on the medical device manufacturing sector, offering targeted investment exposure to healthcare equipment companies. A prominent example is the iShares U.S.

No, IHS Holding Ltd. (NYSE: IHS) does not pay a dividend.

Evaluating whether specific assets or funds operating under the acronym IHE represent a sound investment requires detailed inspection of their underlying financial fundamentals, asset classes, and risk profiles.

Financial market analysts tracking the iShares U.S.

Evaluating the iShares U.S. Medical Devices ETF as an equity purchase involves analyzing its underlying basket of specialized healthcare equities, expense ratios, and broader macroeconomic interest rate environments.

The iShares U.S. Medical Devices ETF is widely regarded as a compelling investment vehicle for portfolios seeking targeted exposure to domestic medical equipment manufacturers, diagnostic firms, and healthcare technology leaders.